News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
158 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21214)
Month
January (3067)
February (2725)
March (2858)
April (2936)
May (3736)
June (2836)
July (2951)
August (2835)
September (2998)
October (3624)
November (3299)
December (2403)
Day
1 (158)
2 (149)
3 (130)
8 (181)
9 (164)
10 (128)
11 (118)
12 (114)
15 (112)
16 (150)
17 (131)
18 (139)
19 (112)
22 (137)
23 (145)
24 (143)
25 (163)
26 (115)
29 (135)
30 (171)
31 (156)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Bio NC
Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp)’s Zero Coupon Convertible Subordinated Notes Due 2021
July 1, 2013
·
1 min read
Genetown
OvaScience Added to Russell 2000® Index
July 1, 2013
·
1 min read
Drug Development
Teva Pharmaceutical Industries Limited Release: Phase III Data Published in Annals of Neurology Show That a Higher Concentration Dose of Glatiramer Acetate Given Three Times a Week Reduced Annualized Relapse Rates in the Treatment of Relapsing-Remitting M
July 1, 2013
·
1 min read
Drug Development
Idera Pharmaceuticals, Inc. Announces Results of Phase 1 Clinical Trial of IMO-8400, Toll-like Receptor Antagonist Drug Candidate for Autoimmune and Inflammatory Diseases
July 1, 2013
·
1 min read
Business
Alliance for Biosecurity Elects Chief Executive Officers of Bavarian Nordic and Elusys Therapeutics, Inc. as New Co-Chairs
July 1, 2013
·
5 min read
Business
Bristol-Myers Squibb Company to Announce Results for Second Quarter 2013 on July 25
July 1, 2013
·
1 min read
RBCC Praises Partner TheraKine’s Fundraising Results in $60 Billion Drug Delivery Market
July 1, 2013
·
1 min read
Policy
NanoViricides, Inc. Submits DengueCide Orphan Drug Designation Letter of Intent to File With the European Medicines Agency
July 1, 2013
·
1 min read
Deals
Sartorius AG Postpones Sale of Industrial Weighing Division
July 1, 2013
·
2 min read
Pharm Country
Regeneron Pharmaceuticals, Inc. Announces First Recipients of Annual “Regeneron Prize for Creative Innovation”
July 1, 2013
·
3 min read
Previous
5 of 16
Next
